Njirimara nke paclitaxel na-ejikọta Albumin

Paclitaxel bụ ọgwụ mgbochi microtubule ọhụrụ, nke a na-ejikarị na ọgwụgwọ ọgwụgwọ ọrịa kansa ovarian, ọrịa ara ara, kansa akpa ume, etuto isi na olu, kansa esophageal, ọrịa kansa afọ na anụ ahụ dị nro. N'afọ ndị na-adịbeghị anya, e mepụtala albumin bound taxol. site n'ịga n'ihu na nyocha nke taxes na ọganihu na-aga n'ihu nke nkà na ụzụ nkwadebe. Ka anyị leba anya n'àgwà nke paclitaxel na-ejikọta Albumin.

Njirimara nke paclitaxel na-ejikọta Albumin

Albumin-bound paclitaxel: nanoparticles mere nke paclitaxel na ụmụ mmadụ serum albumin site na teknụzụ ịma jijiji dị elu, otu albumin molecule na mkpụrụ ndụ paclitaxel asaa na-ejikọta, yana ọrụ nke albumin receptor Gp60 na akpụkpọ ahụ cell na cysteine ​​ọgaranya acidic secretory albumen. A na-eji SPARC) na anụ ahụ tumor iji kwalite ọgwụ iji banye n'ime mkpụrụ ndụ tumo ma mụbaa mmetụta chemotherapy.

1. Nchekwa

Albumin-bound paclitaxel: ọ dịghị mmanu polyoxyethyl castor mmanụ na-enye ume ọhụrụ achọrọ, nke nwere ike ịbawanye dose nke paclitaxel n'enweghị nsogbu, mee ka oge infusion dị mkpụmkpụ, ọ nweghịkwa ọgwụgwọ achọrọ.

2. Ngwọta

Albumin-bound paclitaxel anaghị achọ ọgwụgwọ mbụ iji gbochie mmeghachi ahụ nfụkasị tupu nchịkwa.

3. Mmeghachi omume ọjọọ

Albumin-bound paclitaxel na paclitaxel liposomes: N'ihi mmụba nke teknụzụ nkwadebe, ọ dịghị mkpa ịgbakwunye ihe ndị dị ka polyoxyethyl castor mmanụ, polysorbate 80, ethanol zuru oke, wdg, na nchekwa ọgwụ na-emeziwanye nke ọma.

4, Ngosipụta

Albumin-bound paclitaxel: akwụkwọ akụkọ dị mkpa na-akọ na otu ọgwụ ya na usoro nchikota ya bụ nhọrọ ọgwụgwọ maka ọrịa kansa ara na-adịghị ahụkebe nke na-aga n'ihu ngwa ngwa ma ọ bụ daa na ọgwụgwọ ọtụtụ ahịrị. Ejiri paclitaxel emeso ya na mbụ, yana mmetụta ndị ọ na-akpata na-anabata ya.

Mara: Enwere ike ịrụ ọrụ yana ngwa ewepụtara n'isiokwu a niile sitere na akwụkwọ ebipụtara.

Yunnan Hande Biotechnology Co., Ltd e ọkachamara na mmepụta nkepaclitaxel APIn'ihi na ihe karịrị 20 afọ, na bụ otu n'ime ụwa kwụụrụ onwe emepụta nke paclitaxel API, a osisi-enwetara mgbochi ọrịa cancer ọgwụ, nke US FDA kwadoro, European EDQM, Australian TGA, Chinese CFDA, India, Japan na ndị ọzọ mba regulatory ụlọ ọrụ. .Hande nwere ike inye ọ bụghị naanị dị elupaclitaxel akụrụngwa,ma ọ bụkwa ọrụ nkwalite teknụzụ metụtara usoro paclitaxel. Maka ozi ndị ọzọ, biko nweere onwe gị ịkpọtụrụ anyị na 18187887160.


Oge nzipu: Dec-29-2022